Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
Arnold
A
A
Division of Medical Oncology, Hamilton Regional Cancer Centre, ON, Canada.
Ayoub
J
J
Douglas
L
L
Hoogendoorn
P
P
Skingley
L
L
Gelmon
K
K
Hirsh
V
V
Eisenhauer
E
E
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D015474:Isotretinoin / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D016898:Interferon-alpha; D015474:Isotretinoin